Mark A. Patterson

Mark Patterson practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Mark Patterson's NPI, 1083645378, was assigned on July 5, 2006. Mark Patterson graduated from Wake Forest School of Medicine in 1994. Mark Patterson's Alabama license number on file is 19396.

Mark Patterson's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Mark Patterson's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Mark Patterson is also affiliated with UAB Hospital. The medical group on file is UAB Medicine. Dmand AI also links Mark Patterson to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Patterson practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Mark Patterson's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Mark Patterson is board certified in surgery by the American Board of Surgery. Dmand AI has Mark Patterson's licenses on file in 3 states: Alabama, South Carolina and Wisconsin.

Dmand AI lists amputation, arterial blot clot /embolism, heart device and aorta surgery and removal of damaged skin or skin graft among the conditions Mark Patterson treats.

CMS data shows 475 Medicare services from Mark Patterson across 11 procedure codes in 2024, for 356 Medicare patients. Medicare paid $13,997 for them.

CMS counts 356 Medicare patients who saw Mark Patterson in 2024. The largest group is 75 to 84, with 149 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mark Patterson's median patient age at 70, with 50% women.

In 2024, Mark Patterson wrote 293 Medicare Part D claims for 65 patients. 79% of them were for generic drugs. CMS names the drug for 196 of them, across 7 drugs with 11 or more claims each, at $41,835 in total drug cost. In 2023, CMS named 183 claims across 9 drugs.

Mark Patterson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 38 papers to Mark Patterson, published from 2007 to 2024. 2020 was the busiest year, with 10. The most frequent topics are Endovascular Procedures, Blood Vessel Prosthesis Implantation and Peripheral Arterial Disease. Mark Patterson has published most often in J Vasc Surg. Mark Patterson's most frequent co-authors are Benjamin J. Pearce, Marc A. Passman and Adam Beck, MD.

CMS Open Payments shows 244 general payments to Mark Patterson from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. W. L. Gore & Associates, Inc. paid the most, $11,533.

Dmand AI lists 2 awards for Mark Patterson, most recently CMS Stage 1 2012 in 2012.

Mark Patterson graduated from Wake Forest School of Medicine in 1994. Mark Patterson is a member of ACS and SVS.

Mark Patterson is in network with 13 carriers, including Aetna, United Healthcare and Cigna. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.